The biopharmaceutical industry faces increasing pressure to:
NIIMBL is exploring flexible and modular manufacturing systems that offer:
This solution is being validated through a Voice-of-Customer (VOC) research initiative that gathers insights from key industry stakeholders to assess demand, functionality needs, adoption barriers, and readiness for implementation.
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Janssen Research & Development, LLC
Cytiva
EMD Millipore Corporation
Eli Lilly and Company
Emerson Automation Solutions
Merck Sharp & Dohme LLC
Sartorius Stedim